DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 211 filers reported holding DENALI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 4.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,738,611 | -30.1% | 1,150,684 | 0.0% | 1.21% | -34.1% |
| Q2 2023 | $33,956,685 | +45.2% | 1,150,684 | +13.4% | 1.84% | +98.5% |
| Q1 2023 | $23,378,319 | -17.2% | 1,014,684 | 0.0% | 0.92% | -25.9% |
| Q4 2022 | $28,218,362 | -9.4% | 1,014,684 | 0.0% | 1.25% | -35.0% |
| Q3 2022 | $31,141,000 | +4.3% | 1,014,684 | 0.0% | 1.92% | +12.6% |
| Q2 2022 | $29,862,000 | -8.5% | 1,014,684 | 0.0% | 1.71% | +14.6% |
| Q1 2022 | $32,642,000 | +118.4% | 1,014,684 | +202.7% | 1.49% | +95.3% |
| Q4 2021 | $14,949,000 | – | 335,184 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |